Health Effects of Benzene Exposure among Children Following a Flaring Incident at the British Petroleum Refinery in Texas City
Human exposure to benzene is associated with multiple adverse health effects leading to hematological malignancies. The objective of this retrospective study was to evaluate the health consequences of benzene exposure in children following a flaring incident at the British petroleum (BP) refinery in...
Saved in:
Published in | Pediatric hematology and oncology Vol. 31; no. 1; pp. 1 - 10 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
England
Informa Healthcare
01.02.2014
Taylor & Francis |
Subjects | |
Online Access | Get full text |
ISSN | 0888-0018 1521-0669 1521-0669 |
DOI | 10.3109/08880018.2013.831511 |
Cover
Abstract | Human exposure to benzene is associated with multiple adverse health effects leading to hematological malignancies. The objective of this retrospective study was to evaluate the health consequences of benzene exposure in children following a flaring incident at the British petroleum (BP) refinery in the Texas City, Texas. The study included children aged <17 years who had been exposed and unexposed to benzene. Using medical charts, clinical data including white blood cell (WBC) counts, platelets counts, hemoglobin, hematocrit, blood urea nitrogen (BUN), creatinine, alkaline phosphatase (ALP), aspartate amino transferase (AST), alanine amino transferase (ALT), and somatic symptom complaints by the children exposed to benzene were reviewed and analyzed. A total of 312 subjects (benzene exposed, n = 157 and unexposed, n = 155) were included. Hematologic analysis showed that WBC counts were significantly decreased in benzene-exposed children compared with the unexposed children (6.8 ± 2.1 versus 7.3 ± 1.7, P = .022). Conversely, platelet (X 103 per μL) counts were increased significantly in the benzene-exposed group compared with the unexposed group (278.4 ± 59.9 versus 261.6 ± 51.7, P = .005). Similarly, benzene-exposed children had significantly higher levels of ALP (183.7± 95.6 versus 165 ± 70.3 IU/L, P = .04), AST (23.6 ± 15.3 versus 20.5 ± 5.5 IU/L, P = .015), and ALT (19.2 ± 7.8 versus 16.9 ± 6.9 IU/L, P = .005) compared with the unexposed children. Together, the results of the study reveal that children exposed to benzene experienced significantly altered blood profiles, liver enzymes, and somatic symptoms indicating that children exposed to benzene are at a higher risk of developing hepatic or blood related disorders. |
---|---|
AbstractList | Human exposure to benzene is associated with multiple adverse health effects leading to hematological malignancies. The objective of this retrospective study was to evaluate the health consequences of benzene exposure in children following a flaring incident at the British petroleum (BP) refinery in the Texas City, Texas. The study included children aged <17 years who had been exposed and unexposed to benzene. Using medical charts, clinical data including white blood cell (WBC) counts, platelets counts, hemoglobin, hematocrit, blood urea nitrogen (BUN), creatinine, alkaline phosphatase (ALP), aspartate amino transferase (AST), alanine amino transferase (ALT), and somatic symptom complaints by the children exposed to benzene were reviewed and analyzed. A total of 312 subjects (benzene exposed, n = 157 and unexposed, n = 155) were included. Hematologic analysis showed that WBC counts were significantly decreased in benzene-exposed children compared with the unexposed children (6.8 ± 2.1 versus 7.3 ± 1.7, P = .022). Conversely, platelet (X 103 per μL) counts were increased significantly in the benzene-exposed group compared with the unexposed group (278.4 ± 59.9 versus 261.6 ± 51.7, P = .005). Similarly, benzene-exposed children had significantly higher levels of ALP (183.7± 95.6 versus 165 ± 70.3 IU/L, P = .04), AST (23.6 ± 15.3 versus 20.5 ± 5.5 IU/L, P = .015), and ALT (19.2 ± 7.8 versus 16.9 ± 6.9 IU/L, P = .005) compared with the unexposed children. Together, the results of the study reveal that children exposed to benzene experienced significantly altered blood profiles, liver enzymes, and somatic symptoms indicating that children exposed to benzene are at a higher risk of developing hepatic or blood related disorders. Human exposure to benzene is associated with multiple adverse health effects leading to hematological malignancies. The objective of this retrospective study was to evaluate the health consequences of benzene exposure in children following a flaring incident at the British petroleum (BP) refinery in the Texas City, Texas. The study included children aged <17 years who had been exposed and unexposed to benzene. Using medical charts, clinical data including white blood cell (WBC) counts, platelets counts, hemoglobin, hematocrit, blood urea nitrogen (BUN), creatinine, alkaline phosphatase (ALP), aspartate amino transferase (AST), alanine amino transferase (ALT), and somatic symptom complaints by the children exposed to benzene were reviewed and analyzed. A total of 312 subjects (benzene exposed, n = 157 and unexposed, n = 155) were included. Hematologic analysis showed that WBC counts were significantly decreased in benzene-exposed children compared with the unexposed children (6.8 ± 2.1 versus 7.3 ± 1.7, P = .022). Conversely, platelet (X 10 3 per μL) counts were increased significantly in the benzene-exposed group compared with the unexposed group (278.4 ± 59.9 versus 261.6 ± 51.7, P = .005). Similarly, benzene-exposed children had significantly higher levels of ALP (183.7± 95.6 versus 165 ± 70.3 IU/L, P = .04), AST (23.6 ± 15.3 versus 20.5 ± 5.5 IU/L, P = .015), and ALT (19.2 ± 7.8 versus 16.9 ± 6.9 IU/L, P = .005) compared with the unexposed children. Together, the results of the study reveal that children exposed to benzene experienced significantly altered blood profiles, liver enzymes, and somatic symptoms indicating that children exposed to benzene are at a higher risk of developing hepatic or blood related disorders. Human exposure to benzene is associated with multiple adverse health effects leading to hematological malignancies. The objective of this retrospective study was to evaluate the health consequences of benzene exposure in children following a flaring incident at the British petroleum (BP) refinery in Texas City, Texas. The study included children aged <17 years who had been exposed and unexposed to benzene. Using medical charts, clinical data including white blood cell (WBC) counts, platelets counts, hemoglobin, hematocrit, blood urea nitrogen (BUN), creatinine, alkaline phosphatase (ALP), aspartate amino transferase (AST), alanine amino transferase (ALT), and somatic symptom complaints by the children exposed to benzene were reviewed and analyzed. A total of 312 subjects (benzene exposed, n = 157 and unexposed, n = 155) were included. Hematologic analysis showed that WBC counts were significantly decreased in benzene-exposed children compared with the unexposed children (6.8 ± 2.1 versus 7.3 ± 1.7, P = .022). Conversely, platelet (X 10(3) per μL) counts were increased significantly in the benzene-exposed group compared with the unexposed group (278.4 ± 59.9 versus 261.6 ± 51.7, P = .005). Similarly, benzene-exposed children had significantly higher levels of ALP (183.7± 95.6 versus 165 ± 70.3 IU/L, P = .04), AST (23.6 ± 15.3 versus 20.5 ± 5.5 IU/L, P = .015), and ALT (19.2 ± 7.8 versus 16.9 ± 6.9 IU/L, P = .005) compared with the unexposed children. Together, the results of the study reveal that children exposed to benzene experienced significantly altered blood profiles, liver enzymes, and somatic symptoms indicating that children exposed to benzene are at a higher risk of developing hepatic or blood related disorders. Human exposure to benzene is associated with multiple adverse health effects leading to hematological malignancies. The objective of this retrospective study was to evaluate the health consequences of benzene exposure in children following a flaring incident at the British petroleum (BP) refinery in Texas City, Texas. The study included children aged <17 years who had been exposed and unexposed to benzene. Using medical charts, clinical data including white blood cell (WBC) counts, platelets counts, hemoglobin, hematocrit, blood urea nitrogen (BUN), creatinine, alkaline phosphatase (ALP), aspartate amino transferase (AST), alanine amino transferase (ALT), and somatic symptom complaints by the children exposed to benzene were reviewed and analyzed. A total of 312 subjects (benzene exposed, n = 157 and unexposed, n = 155) were included. Hematologic analysis showed that WBC counts were significantly decreased in benzene-exposed children compared with the unexposed children (6.8 ± 2.1 versus 7.3 ± 1.7, P = .022). Conversely, platelet (X 10(3) per μL) counts were increased significantly in the benzene-exposed group compared with the unexposed group (278.4 ± 59.9 versus 261.6 ± 51.7, P = .005). Similarly, benzene-exposed children had significantly higher levels of ALP (183.7± 95.6 versus 165 ± 70.3 IU/L, P = .04), AST (23.6 ± 15.3 versus 20.5 ± 5.5 IU/L, P = .015), and ALT (19.2 ± 7.8 versus 16.9 ± 6.9 IU/L, P = .005) compared with the unexposed children. Together, the results of the study reveal that children exposed to benzene experienced significantly altered blood profiles, liver enzymes, and somatic symptoms indicating that children exposed to benzene are at a higher risk of developing hepatic or blood related disorders.Human exposure to benzene is associated with multiple adverse health effects leading to hematological malignancies. The objective of this retrospective study was to evaluate the health consequences of benzene exposure in children following a flaring incident at the British petroleum (BP) refinery in Texas City, Texas. The study included children aged <17 years who had been exposed and unexposed to benzene. Using medical charts, clinical data including white blood cell (WBC) counts, platelets counts, hemoglobin, hematocrit, blood urea nitrogen (BUN), creatinine, alkaline phosphatase (ALP), aspartate amino transferase (AST), alanine amino transferase (ALT), and somatic symptom complaints by the children exposed to benzene were reviewed and analyzed. A total of 312 subjects (benzene exposed, n = 157 and unexposed, n = 155) were included. Hematologic analysis showed that WBC counts were significantly decreased in benzene-exposed children compared with the unexposed children (6.8 ± 2.1 versus 7.3 ± 1.7, P = .022). Conversely, platelet (X 10(3) per μL) counts were increased significantly in the benzene-exposed group compared with the unexposed group (278.4 ± 59.9 versus 261.6 ± 51.7, P = .005). Similarly, benzene-exposed children had significantly higher levels of ALP (183.7± 95.6 versus 165 ± 70.3 IU/L, P = .04), AST (23.6 ± 15.3 versus 20.5 ± 5.5 IU/L, P = .015), and ALT (19.2 ± 7.8 versus 16.9 ± 6.9 IU/L, P = .005) compared with the unexposed children. Together, the results of the study reveal that children exposed to benzene experienced significantly altered blood profiles, liver enzymes, and somatic symptoms indicating that children exposed to benzene are at a higher risk of developing hepatic or blood related disorders. |
Author | Reddy, G. Kesava D'Andrea, Mark A. |
Author_xml | – sequence: 1 givenname: Mark A. surname: D'Andrea fullname: D'Andrea, Mark A. email: kreddy_usa@yahoo.com, mmmeead@aol.com, mmmeead@aol.com, kreddy_usa@yahoo.com organization: University Cancer and Diagnostic Centers – sequence: 2 givenname: G. Kesava surname: Reddy fullname: Reddy, G. Kesava email: kreddy_usa@yahoo.com, mmmeead@aol.com, mmmeead@aol.com, kreddy_usa@yahoo.com organization: University Cancer and Diagnostic Centers |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/24088183$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkUFvEzEQhS1URNPCP0DIRy4b7F1vYnMAtVFCK1UCoXK2JutZ1pXXDrZXbTjw29klzQEO5TTW-HtPo_fOyIkPHgl5zdm84ky9Y1JKxricl4xXc1nxmvNnZMbrkhdssVAnZDYhxcSckrOU7hhjZbUsX5DTUoxfXFYz8usKweWOrtsWm5xoaOkl-p_oka4fdiENESn0wX-nq846E9HTTXAu3NtxBXTjIE6va99Ygz5TyDR3SC-jzTZ19AvmGBwOPf2KrfUY99R6eosPkOjK5v1L8rwFl_DV4zwn3zbr29VVcfP50_Xq4qZoBJe5MGZZiq0ol6o2RhhURqGChpcKapQSoCoFtqxmDLbVgm-NWLRcKQUGRkbI6py8PfjuYvgxYMq6t6lB58BjGJLmQomKLZmoR_TNIzpsezR6F20Pca-PmY3A-wPQxJBSxFY3NkO2wecI1mnO9FSQPhakp4L0oaBRLP4RH_3_I_t4kFnfhtjDfYjO6Ax7F2IbYUw_TeonHT785dD96b2BiPouDNGP6T99wm9Itbop |
CitedBy_id | crossref_primary_10_2139_ssrn_2516589 crossref_primary_10_1177_0009922815594358 crossref_primary_10_1007_s11356_022_18790_2 crossref_primary_10_1177_0009922816641463 crossref_primary_10_1289_EHP11750 crossref_primary_10_1017_dmp_2015_160 crossref_primary_10_7189_jogh_14_04045 crossref_primary_10_1016_j_envint_2018_08_056 crossref_primary_10_1186_1476_069X_13_82 crossref_primary_10_1177_07482337231212693 crossref_primary_10_3390_toxics10110678 crossref_primary_10_1016_j_scitotenv_2021_148135 crossref_primary_10_1080_10590501_2015_1002999 crossref_primary_10_1016_j_envres_2017_06_029 crossref_primary_10_1017_dmp_2017_59 crossref_primary_10_1186_s12944_023_01895_z crossref_primary_10_2478_intox_2020_0009 crossref_primary_10_1186_1476_069X_13_115 crossref_primary_10_3390_ijerph20032275 crossref_primary_10_1177_2333794X18789275 crossref_primary_10_1097_JOM_0000000000000288 crossref_primary_10_29252_ismj_21_2_162 crossref_primary_10_4103_ijpvm_IJPVM_495_18 crossref_primary_10_3390_toxics10070351 crossref_primary_10_3390_atmos8060107 |
Cites_doi | 10.1520/JFS14396J 10.1016/j.cbi.2010.01.002 10.1080/15287390802477338 10.1023/A:1019579430978 10.1016/j.mrrev.2005.04.003 10.1289/ehp.1002546 10.1289/ehp.11593 10.1146/annurev.publhealth.012809.103646 10.1093/toxsci/66.2.185 10.1016/S0016-5085(19)34763-8 10.1007/s10654-012-9727-1 10.1289/ehp.961041365 10.1002/ajim.20592 10.1111/1539-6924.00295 10.1016/S1383-5742(03)00053-X 10.1016/S0016-5085(62)80053-5 10.1080/00984100050166334 10.1177/0748233707080907 10.1186/1476-069X-9-31 10.1093/annhyg/10.4.317 10.1038/sj.leu.2401981 10.1520/JFS13444J 10.1080/00039890409605165 10.3109/02770903.2010.538106 10.1081/PFC-100104188 10.1289/ehp.1103921 10.1158/1055-9965.EPI-06-0262 |
ContentType | Journal Article |
Copyright | 2014 Informa Healthcare USA, Inc. 2014 |
Copyright_xml | – notice: 2014 Informa Healthcare USA, Inc. 2014 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.3109/08880018.2013.831511 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1521-0669 |
EndPage | 10 |
ExternalDocumentID | 24088183 10_3109_08880018_2013_831511 831511 |
Genre | Research Article Journal Article |
GeographicLocations | Texas |
GeographicLocations_xml | – name: Texas |
GroupedDBID | --- 00X 03L 0BK 0R~ 123 29O 36B 4.4 53G AAJNR AALUX AAMIU AAPUL AAPXX AAQRR ABBKH ABDBF ABEIZ ABLKL ABOCM ABPTK ABUPF ACENM ACFUF ACGEJ ACGFS ACLSK ADCVX ADFCX ADRBQ ADXPE AECIN AEGXH AENEX AEOZL AEXWM AEYQI AFKVX AFWLO AGDLA AGFJD AGRBW AGYJP AIJEM AIRBT AJWEG AKBVH ALIIL ALMA_UNASSIGNED_HOLDINGS ALQZU AMDAE BABNJ BLEHA BOHLJ CCCUG CS3 DKSSO DU5 EAP EBB EBC EBD EBS EBX EJD EMB EMK EMOBN EPL ESX F5P H13 HZ~ J.N KRBQP KSSTO KWAYT KYCEM M44 M4Z O9- P2P RNANH RVRKI SV3 TFDNU TFL TFW TUS UEQFS V1S ~1N ABJNI ABLIJ ABXYU ACIEZ ACUHS ALYBC TBQAZ TDBHL TERGH TUROJ .55 5VS AAGDL AALIY AAORF AAYXX ABWCV ABWVI ABZEW ACKZS ACOPL ACYZI ADFOM ADFZZ ADYSH AEIIZ AFLEI AFRVT AJVHN AMPGV AWYRJ BRMBE CAG CITATION COF CYYVM CZDIS DRXRE DWTOO JENTW LJTGL NUSFT QQXMO UDS X7M CGR CUY CVF ECM EIF NPM TASJS 7X8 |
ID | FETCH-LOGICAL-c418t-dd724b42795dd4de9d9e9ac129a5e88aa324ef0500ab361bd46f1999ada129483 |
ISSN | 0888-0018 1521-0669 |
IngestDate | Fri Sep 05 09:37:33 EDT 2025 Mon Jul 21 06:04:21 EDT 2025 Tue Jul 01 00:44:54 EDT 2025 Thu Apr 24 23:03:20 EDT 2025 Wed Dec 25 09:05:28 EST 2024 Wed Jun 21 01:43:41 EDT 2023 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c418t-dd724b42795dd4de9d9e9ac129a5e88aa324ef0500ab361bd46f1999ada129483 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 24088183 |
PQID | 1494307045 |
PQPubID | 23479 |
PageCount | 10 |
ParticipantIDs | crossref_citationtrail_10_3109_08880018_2013_831511 informaworld_taylorfrancis_310_3109_08880018_2013_831511 proquest_miscellaneous_1494307045 crossref_primary_10_3109_08880018_2013_831511 pubmed_primary_24088183 informahealthcare_journals_10_3109_08880018_2013_831511 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 20140201 2/1/2014 2014-02-00 2014-Feb |
PublicationDateYYYYMMDD | 2014-02-01 |
PublicationDate_xml | – month: 2 year: 2014 text: 20140201 day: 1 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | Pediatric hematology and oncology |
PublicationTitleAlternate | Pediatr Hematol Oncol |
PublicationYear | 2014 |
Publisher | Informa Healthcare Taylor & Francis |
Publisher_xml | – name: Informa Healthcare – name: Taylor & Francis |
References | U.S. Environmental Protection Agency (CIT0022) 1998 CIT0034 Droz P (CIT0033) 1989; 46 Evans L (CIT0017) 2010 Docter HJ (CIT0037) 1967; 10 Reynolds P (CIT0024) 2002; 13 Weng HH (CIT0025) 2009; 72 Rothman N (CIT0028) 1996; 104 Barbera N (CIT0007) 1998; 43 CIT0016 Smith MT (CIT0002) 2010; 31 CIT0018 Sebesta DG (CIT0036) 1964; 47 Evans L. (CIT0015) 2010 CIT0019 Snyder R (CIT0004) 2000; 61 McHale CM (CIT0029) 2010; 119 Avis SP (CIT0006) 1993; 38 Goldman LR (CIT0011) 1995; 103 U.S. Environmental Protection Agency (CIT0021) 2003 Tunsaringkarn T (CIT0040) 2013; 1 CIT0001 CIT0023 Pyatt D (CIT0020) 2010; 184 Polin SG (CIT0035) 1962; 42 Neri M (CIT0012) 2006; 612 Ray MR (CIT0030) 2007; 23 Vinceti M (CIT0009) 2012; 27 Innerfield F. (CIT0032) 1960 Winek CL (CIT0008) 1971; 13 Kim S (CIT0014) 2006; 15 Whysner J (CIT0013) 2004; 566 Hattis D (CIT0027) 2003; 23 Ceresa C (CIT0031) 1960; 51 McDonald TA (CIT0038) 2001; 15 Inoue O (CIT0039) 1986; 43 Costantini AS (CIT0003) 2008; 51 Marchetti F (CIT0005) 2012; 120 CIT0026 Whitworth KW (CIT0010) 2008; 116 |
References_xml | – volume: 43 start-page: 1250 issue: 6 year: 1998 ident: CIT0007 publication-title: J Forensic Sci. doi: 10.1520/JFS14396J – volume: 184 start-page: 151 issue: 1 year: 2010 ident: CIT0020 publication-title: Chem Biol Interact. doi: 10.1016/j.cbi.2010.01.002 – volume: 72 start-page: 83 issue: 2 year: 2009 ident: CIT0025 publication-title: J Toxicol Environ Health A doi: 10.1080/15287390802477338 – volume: 43 start-page: 692 issue: 10 year: 1986 ident: CIT0039 publication-title: Br J Ind Med. – volume-title: Enzymes in clinical chemistry year: 1960 ident: CIT0032 – volume: 13 start-page: 665 issue: 7 year: 2002 ident: CIT0024 publication-title: Cancer Causes Control doi: 10.1023/A:1019579430978 – volume: 612 start-page: 14 issue: 1 year: 2006 ident: CIT0012 publication-title: Mutat Res. doi: 10.1016/j.mrrev.2005.04.003 – volume-title: Emissions Event (Incident No. 138052) Review on British Petrolium products, North America (Investigation No. 824714) year: 2010 ident: CIT0017 – volume: 1 start-page: 1 year: 2013 ident: CIT0040 publication-title: Int J Environ Pollut Solutions – volume: 119 start-page: 628 issue: 5 year: 2010 ident: CIT0029 publication-title: Environ Health Perspect. doi: 10.1289/ehp.1002546 – volume: 46 start-page: 547 year: 1989 ident: CIT0033 publication-title: Brit J Ind Med. – volume-title: BP's 40-Day Emissions Event year: 2010 ident: CIT0015 – volume: 116 start-page: 1576 issue: 11 year: 2008 ident: CIT0010 publication-title: Environ Health Perspect. doi: 10.1289/ehp.11593 – volume: 31 start-page: 133 year: 2010 ident: CIT0002 publication-title: Annu Rev Public Health doi: 10.1146/annurev.publhealth.012809.103646 – ident: CIT0026 doi: 10.1093/toxsci/66.2.185 – volume: 47 start-page: 166 year: 1964 ident: CIT0036 publication-title: Gastroenterology doi: 10.1016/S0016-5085(19)34763-8 – volume: 27 start-page: 781 issue: 10 year: 2012 ident: CIT0009 publication-title: Eur J Epidemiol. doi: 10.1007/s10654-012-9727-1 – volume: 13 start-page: 259 issue: 5 year: 1971 ident: CIT0008 publication-title: J Occup Med. – volume: 104 start-page: 1365 issue: 6 year: 1996 ident: CIT0028 publication-title: Environ Health Perspect. doi: 10.1289/ehp.961041365 – volume-title: Carcinogenic Effects of Benzene: An Update year: 1998 ident: CIT0022 – volume: 51 start-page: 803 issue: 11 year: 2008 ident: CIT0003 publication-title: Am J Ind Med. doi: 10.1002/ajim.20592 – volume: 51 start-page: 3544 year: 1960 ident: CIT0031 publication-title: Minerva Med. – ident: CIT0016 – volume: 23 start-page: 117 issue: 1 year: 2003 ident: CIT0027 publication-title: Risk Anal. doi: 10.1111/1539-6924.00295 – volume: 566 start-page: 99 issue: 2 year: 2004 ident: CIT0013 publication-title: Mutat Res. doi: 10.1016/S1383-5742(03)00053-X – ident: CIT0018 – volume: 42 start-page: 431 year: 1962 ident: CIT0035 publication-title: Gastroenterology doi: 10.1016/S0016-5085(62)80053-5 – volume: 61 start-page: 339 issue: 5 year: 2000 ident: CIT0004 publication-title: J Toxicol Environ Health A doi: 10.1080/00984100050166334 – volume: 23 start-page: 167 issue: 3 year: 2007 ident: CIT0030 publication-title: Toxicol Ind Health doi: 10.1177/0748233707080907 – ident: CIT0001 doi: 10.1186/1476-069X-9-31 – volume: 10 start-page: 317 issue: 4 year: 1967 ident: CIT0037 publication-title: Ann Occup Hyg. doi: 10.1093/annhyg/10.4.317 – volume: 15 start-page: 10 issue: 1 year: 2001 ident: CIT0038 publication-title: Leukemia. doi: 10.1038/sj.leu.2401981 – volume: 38 start-page: 599 issue: 3 year: 1993 ident: CIT0006 publication-title: J Forensic Sci. doi: 10.1520/JFS13444J – volume: 103 start-page: 13 issue: 6 year: 1995 ident: CIT0011 publication-title: Environ Health Perspect. – ident: CIT0023 doi: 10.1080/00039890409605165 – ident: CIT0019 doi: 10.3109/02770903.2010.538106 – ident: CIT0034 doi: 10.1081/PFC-100104188 – volume-title: Integrated Risk Information System (IRIS): Benzene year: 2003 ident: CIT0021 – volume: 120 start-page: 229 issue: 2 year: 2012 ident: CIT0005 publication-title: Environ Health Perspect. doi: 10.1289/ehp.1103921 – volume: 15 start-page: 2246 issue: 11 year: 2006 ident: CIT0014 publication-title: Cancer Epidemiol Biomarkers Prev. doi: 10.1158/1055-9965.EPI-06-0262 |
SSID | ssj0002372 |
Score | 2.1200871 |
Snippet | Human exposure to benzene is associated with multiple adverse health effects leading to hematological malignancies. The objective of this retrospective study... |
SourceID | proquest pubmed crossref informaworld informahealthcare |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1 |
SubjectTerms | Accidents, Occupational Adolescent Air Pollutants - toxicity Benzene - toxicity benzene poisoning Blood Cell Count blood disorders chemical exposure Chemical Industry Child Creatinine - blood Digestive System Diseases - blood Digestive System Diseases - chemically induced Digestive System Diseases - epidemiology Environmental Exposure Exanthema - chemically induced Exanthema - epidemiology Female health impact hematological toxicity Hemoglobins - analysis hepatotoxicity Humans Kidney - drug effects Liver - drug effects Liver Function Tests Male Nervous System Diseases - chemically induced Nervous System Diseases - epidemiology Petroleum petroleum refinery Phenol - urine Respiratory Tract Diseases - chemically induced Respiratory Tract Diseases - epidemiology Retrospective Studies Sex Factors Texas urinary metabolites of benzene |
Title | Health Effects of Benzene Exposure among Children Following a Flaring Incident at the British Petroleum Refinery in Texas City |
URI | https://www.tandfonline.com/doi/abs/10.3109/08880018.2013.831511 https://www.ncbi.nlm.nih.gov/pubmed/24088183 https://www.proquest.com/docview/1494307045 |
Volume | 31 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZgKyEuqLy3PGQkOK1SNrETO8c-KBWoHNBW6i1y_FCR2qRiswX1wG9n_Ep2YUuBS7RK7ETZ7_N47Mx8g9BrlaqUpUYmmclVQkstElEKnqiU1JwLWRq3lX30qTg8ph9O8pMhVtVll3T1trxam1fyP6jCOcDVZsn-A7L9TeEE_AZ84QgIw_GvMA45REsxGbVursB6WeH-du6-DbhiQn3KtgHY228uMXFiYFHrM1qkrSwa8xonUefIFttqz_TiHDAwNkfQpQjO9Hcxn-x96Va-B_cVPyZOBHYQdmobubJxv_8mYy6IUsRMoWE39bNW3uS_n3zUc3EplrckUhqjmO2MEsxoZuOpfBGWaGeDtV_mkzea6TpTTrwSKhhBbgsH2iA8ss0JOCgrzQGQi3MHr9VqA--DDBNbH24YL91GGxkDF2uENnZ293cP-ik7IyzzeZX2sW_XPdSqRofbrLgwm0Hg9rQP1_tF9Pb6pYtzYWab6F5Ye-AdT6T76JZuHqA7RyG64iH64fmEA59wa3DgE458wo5POPIJ93zCAgc-4cgnLDoMfMKBT7jnE458gqbY8QlbPj1CxwfvZnuHSajPkUia8i5RimW0phkrc6Wo0qUqdSkkeJAi1zDQBTjr2kzz6VTUpEhrRQtjVS-EEtCGcvIYjZq20U8RJkoWGTeSaF7QGnpLVjCmVGFMysHJGiMS__JKBvF6W0PlrIJFrMWsiphVFrPKYzZGSd_rwou33NCe_YZmFcb7_IaefBnzqnPbbcbXxrHd_tT1VeRHBabdfq8TjW4X8EBqayMwWHSN0RNPnP41Ihe3rr3yDN0dxuZzNOq-LvQLcKC7-mWg_086xsF2 |
linkProvider | EBSCOhost |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Health+effects+of+benzene+exposure+among+children+following+a+flaring+incident+at+the+British+Petroleum+Refinery+in+Texas+City&rft.jtitle=Pediatric+hematology+and+oncology&rft.au=D%27Andrea%2C+Mark+A&rft.au=Reddy%2C+G+Kesava&rft.date=2014-02-01&rft.eissn=1521-0669&rft.volume=31&rft.issue=1&rft.spage=1&rft_id=info:doi/10.3109%2F08880018.2013.831511&rft_id=info%3Apmid%2F24088183&rft.externalDocID=24088183 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0888-0018&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0888-0018&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0888-0018&client=summon |